Literature DB >> 17141372

A model genetic system for testing the in vivo function of peptide toxins.

Hugo W Tedford1, Francesco Maggio, Robert A Reenan, Glenn King.   

Abstract

We have developed a model genetic system for analyzing the function of peptide toxins from animal venoms. We engineered and propagated strains of Drosophila melanogaster expressing heat-inducible transgenes encoding either kappa-ACTX-Hv1c or omega-ACTX-Hv1a, two insect-specific neurotoxic peptides found in the venom of the Australian funnel-web spider Hadronyche versuta. Heat induction of transgene expression for 20 min was sufficient to kill all transgenic flies, indicating that the ion channels targeted by these toxins are viable insecticide targets. The unusual phenotype of flies induced to express omega-ACTX-Hv1a recapitulates that of a hypomorphic allele of the high-voltage-activated calcium channel Dmca1D, suggesting that this is likely to be the target of omega-ACTX-Hv1a.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141372     DOI: 10.1016/j.peptides.2006.08.026

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Diversification of a single ancestral gene into a successful toxin superfamily in highly venomous Australian funnel-web spiders.

Authors:  Sandy S Pineda; Brianna L Sollod; David Wilson; Aaron Darling; Kartik Sunagar; Eivind A B Undheim; Laurence Kely; Agostinho Antunes; Bryan G Fry; Glenn F King
Journal:  BMC Genomics       Date:  2014-03-05       Impact factor: 3.969

Review 2.  Spider-venom peptides as bioinsecticides.

Authors:  Monique J Windley; Volker Herzig; Sławomir A Dziemborowicz; Margaret C Hardy; Glenn F King; Graham M Nicholson
Journal:  Toxins (Basel)       Date:  2012-03-22       Impact factor: 4.546

3.  Isolation of an orally active insecticidal toxin from the venom of an Australian tarantula.

Authors:  Margaret C Hardy; Norelle L Daly; Mehdi Mobli; Rodrigo A V Morales; Glenn F King
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.